[1]
“A case report on management of sero negative spondyloarthropathy”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 6, no. 1, pp. 53–56, Apr. 2021, doi: 10.61096/ijrpp.v6.iss1.2017.53-56.